Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

The Price of Prevention: Cost Effectiveness of Biomedical HIV Prevention Strategies in South Africa.

Moodley N, Gray G, Bertram M.

Clin Res HIV AIDS. 2016;3(1). pii: 1031. Epub 2016 Nov 27.

2.

The Cost of Voluntary Medical Male Circumcision in South Africa.

Tchuenche M, Palmer E, Haté V, Thambinayagam A, Loykissoonlal D, Njeuhmeli E, Forsythe S.

PLoS One. 2016 Oct 26;11(10):e0160207. doi: 10.1371/journal.pone.0160207. eCollection 2016. Erratum in: PLoS One. 2017 Jan 3;12 (1):e0169710.

3.

Non-therapeutic infant male circumcision. Evidence, ethics, and international law perspectives.

Alkhenizan A, Elabd K.

Saudi Med J. 2016 Sep;37(9):941-7. doi: 10.15537/smj.2016.9.14519.

4.

Trends in the Marginal Cost of Male Circumcision in Rural Rakai Uganda.

Alfonso YN, Bishai D, Nantongo A, Kakembo R, Kobusinge S, Kacker S, Kigozi G, Gray R.

J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):564-571.

PMID:
27509246
5.

Modeling and Cost-Effectiveness in HIV Prevention.

Jacobsen MM, Walensky RP.

Curr HIV/AIDS Rep. 2016 Feb;13(1):64-75. doi: 10.1007/s11904-016-0303-2. Review.

7.

Does Routine Pathology Analysis of Adult Circumcision Tissue Identify Penile Cancer?

Shah VS, Jung NL, Lee DK, Nepple KG.

Urology. 2015 Jun;85(6):1431-1434. doi: 10.1016/j.urology.2014.12.065. Epub 2015 Apr 11.

8.

How do you circumcise a nation? The Rwandan case study.

Mutabazi V, Forrest JI, Ford N, Mills EJ.

BMC Med. 2014 Oct 6;12:184. doi: 10.1186/s12916-014-0184-4.

9.

Differential compartmentalization of HIV-targeting immune cells in inner and outer foreskin tissue.

Liu A, Yang Y, Liu L, Meng Z, Li L, Qiu C, Xu J, Zhang X.

PLoS One. 2014 Jan 15;9(1):e85176. doi: 10.1371/journal.pone.0085176. eCollection 2014.

10.

Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections.

Tobian AA, Kacker S, Quinn TC.

Annu Rev Med. 2014;65:293-306. doi: 10.1146/annurev-med-092412-090539. Epub 2013 Sep 16. Review.

11.

Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women.

Ndeffo Mbah ML, Poolman EM, Atkins KE, Orenstein EW, Meyers LA, Townsend JP, Galvani AP.

PLoS Negl Trop Dis. 2013 Aug 1;7(8):e2346. doi: 10.1371/journal.pntd.0002346. Print 2013.

12.

Review: a critical evaluation of arguments opposing male circumcision for HIV prevention in developed countries.

Morris BJ, Bailey RC, Klausner JD, Leibowitz A, Wamai RG, Waskett JH, Banerjee J, Halperin DT, Zoloth L, Weiss HA, Hankins CA.

AIDS Care. 2012;24(12):1565-75. doi: 10.1080/09540121.2012.661836. Epub 2012 Mar 28. Review.

13.

A 'snip' in time: what is the best age to circumcise?

Morris BJ, Waskett JH, Banerjee J, Wamai RG, Tobian AA, Gray RH, Bailis SA, Bailey RC, Klausner JD, Willcourt RJ, Halperin DT, Wiswell TE, Mindel A.

BMC Pediatr. 2012 Feb 28;12:20. doi: 10.1186/1471-2431-12-20. Review.

14.

Voluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern Africa.

Bertrand JT, Njeuhmeli E, Forsythe S, Mattison SK, Mahler H, Hankins CA.

PLoS One. 2011;6(11):e27562. doi: 10.1371/journal.pone.0027562. Epub 2011 Nov 29.

15.

Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa.

Wamai RG, Morris BJ, Bailis SA, Sokal D, Klausner JD, Appleton R, Sewankambo N, Cooper DA, Bongaarts J, de Bruyn G, Wodak AD, Banerjee J.

J Int AIDS Soc. 2011 Oct 20;14:49. doi: 10.1186/1758-2652-14-49. Review.

16.

The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model.

Hontelez JA, Nagelkerke N, Bärnighausen T, Bakker R, Tanser F, Newell ML, Lurie MN, Baltussen R, de Vlas SJ.

Vaccine. 2011 Aug 18;29(36):6100-6. doi: 10.1016/j.vaccine.2011.06.059. Epub 2011 Jun 22.

Supplemental Content

Support Center